Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

- PMLiVE

Pre-chemotherapy indication for Xtandi in prostate cancer

Astellas drug set to compete with J&J’s Zytiga

- PMLiVE

Gopa Mitra retires from PAGB

She steps down after 34 years at organisation

- PMLiVE

The definition of value

Aligning the thoughts of biopharma and other healthcare stakeholders

- PMLiVE

Dive in: gaining leadership in a therapeutic area

Gaining long-term leadership in a therapy area can be commercially invaluable

- PMLiVE

Mylan buys US rights to blood clot drug

$300m deal to acquire Arixtra from South Africa’s Aspen

- PMLiVE

Second time lucky for Takeda’s obesity drug

FDA approves Contrave three years after initial rejection

- PMLiVE

Baxter names biopharma spin-off Baxalta

Will separate from medical technology business

EU flag

Lantus faces first biosimilar rival in Europe

Sanofi prepares for insulin challenge from Boehringer and Lilly

- PMLiVE

Liberation strengthens team with new member

Edward Mullin has been appointed as account coordinator

- PMLiVE

Pharma spent $342m on journal advertising in first half of 2014

J&J led spending and Invokana was most advertised brand

- PMLiVE

Bayer partners with Glamour on female empowerment

Campaign to support the contraception Skyla

Pharma deals during August 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links